With the introduction of Osteoboost, an innovative device that aims to prevent osteoporosis in menopausal women, we are seeing significant progress in the treatment of osteopenia. Approved by the FDA and developed in part with NASA, Osteoboost stands out as the first device of its kind to provide preventative treatment for bone density, without the use of drugs.
Pioneering work
Osteoboost represents a breakthrough in the field ofosteopenia, a condition characterized by reduced bone density which, if left untreated, can progress to osteoporosis. The latter is a disease that makes bones fragile and more susceptible to fractures. According to statistics, one in two women who has passed menopause is affected by osteoporosis. This shows how such a device could become important.
The technology behind Osteoboost originates, as mentioned, from NASA research. The US space agency has explored different methods to prevent bone density loss in zero-gravity environments, such as space. This device uses gentle vibration to mechanically stimulate bones, particularly in the hips and spine, areas frequently affected by reduced bone density.
Promising results from clinical trials
Clinical studies have shown that incorporating Osteoboost into a patient's treatment plan leads to visible improvements in bone density over time. A study supported by the US Health Service (I link it here) found that women in their 50s and 60s without any intervention lost 3,4% of their bone density in 12 months, while those who used the device they recorded a much smaller loss, just 0,5%.
To get maximum benefits, data shows you need to wear an Osteoboost belt for 30 minutes a day, or at least five times a week. Its ease of use allows it to be easily integrated into your daily routine: you can wear it at work, or during common activities such as walking the dog or doing household chores.
Beyond traditional treatments for osteopenia
Currently, standard strategies to prevent osteoporosis during the osteopenia phase focus on several elements. Among the main ones are those linked to lifestyle, such as a balanced diet rich in calcium, physical exercises and reduction of the risk of falls. However, the impact of these measures is often limited. Osteoboost offers a potentially more effective and direct solution to slowing the loss of bone density and strength.
Although the device is not yet available for sale, it is possible to register to receive notifications on its release on the market. Shipping is expected to begin by the end of 2024 and pre-orders will be accepted in the coming months. To purchase it, you will need a doctor's prescription, and the cost may vary depending on the country.
